alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Resource Related Research Projects (R24 Clinical Trial Not Allowed).                    

*Date:*                         February 23, 2021.                    

*Time:*                         10:00 a.m. to 1:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G20, Rockville, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Zhuqing (Charlie) Li, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G20, Rockville, MD 20852, (240) 669-5068,                         *zhuqing.li@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: January 26, 2021.

Tyeshia M. Roberson,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2021-02275 Filed 2-3-21; 8:45 am]

BILLING CODE 4140-01-P
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
PARTNERSHIP'S STATEMENTS OF EARNINGS AND BALANCE SHEETS AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                       5,849,983
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             5,849,983
<PP&E>                                       5,665,419
<DEPRECIATION>                               2,506,949
<TOTAL-ASSETS>                              15,286,368
<CURRENT-LIABILITIES>                           47,372
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                 (1,128,437)
<TOTAL-LIABILITY-AND-EQUITY>                15,286,368
<SALES>                                              0
<TOTAL-REVENUES>                             2,578,466
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             1,386,758
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,295,090
<INCOME-PRETAX>                              1,798,640
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          1,798,640
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,798,640
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
Exhibit 10.1

LOGO

Lee P. Brennan

Vice President

Mid-Corporation Banking Credit

June 21, 2006

CDI Corp.

1717 Arch Street, 35th Floor

Philadelphia, PA 19103

Attention: Scott J. Salantrie

Dear Scott:

This letter supersedes and replaces our advice of line of credit letter dated February 27, 2006.

We are pleased to advise you that based upon your annual financial statements for the fiscal year 2005, and your filings of interim information contained in your 10-Q dated as of March 31, 2006 JPMorgan Chase
Bank (the Bank) has approved your request for a line of credit in the aggregate amount of $35,000,000.00. Our officers may, at their discretion, make short term loans to CDI Corporation, on such terms as are mutually agreed upon between
us from time to time.

Borrowings under this line are intended to be used to meet your normal short term capital needs and will bear interest at such a
rate as shall be mutually agreed upon by each of us from time to time.

As this line is not a commitment, credit availability is, in addition, subject to
your execution and delivery of such documentation as the Bank deems appropriate and the receipt and continuing satisfaction with current financial information (including without limitation audited annual and unaudited quarterly financial statements,
promptly prepared and received), which information will be furnished to the Bank as it may from time to time reasonably request, and continuing satisfaction with your financial condition, business affairs and prospects. This line expires on
August 31, 2006.

We are pleased to be of service and trust you will call upon us to assist in any of your banking requirements.



|                   |  | 
|------------------ |  | 
|Very truly yours,  |  | 
|                   | 
|/s/ Lee P. Brennan |  | 

JPMorgan Chase Bank, N.A.  Commercial Banking  Mid-Corporate Banking Credit  NY1-L280,
277 Park Avenue, 14th Floor, New York, NY 10172



---

June 21, 2006

ENDORSEMENT NO. 3

The Promissory Note dated November 16, 2004 (the Note) of
CDI CORP.(the Borrower) as amended by Endorsement 1 and Endorsement 2 to which this Endorsement No. 3 is attached and evidencing a $35,000,000 uncommitted line of credit facility (Line of Credit) extended by
JPMORGAN CHASE BANK,N.A., formerly JPMorganChase Bank (the Bank) to the Borrower is hereby amended by:



| | 1. | deleting June 30, 2006 in the first paragraph of the Note and substituting therefore August 31, 2006 as the amended Maturity Date of the Note and expiration
date for the Line of Credit.
| | -- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



CDI CORP.By:

/s/ Mark A. KerschnerTitle:JPMORGAN CHASE BANK, N.A.By:

/s/ Lee P. BrennanVice President
#### John Severson, appellee, v. The American Insurance Company, appellant.

Gen. No. 7,654.

Action upon fire insurance policy. Judgment for plaintiff. Appeal from the Circuit Court of Grundy county; the Hon. G. O. Dietz, Judge, presiding. Heard in this court at the April term, 1926.

Reversed and remanded.

Opinion filed June 25, 1926.

Donovan, Bray & Gray and Frank L. Flood, for appellant; James A. Bray and James E. Burke, of counsel.

Hayes, Munts & Young, for appellee.

Mr. Presiding Justice Partlow

delivered the opinion of the court.
# C_2019167EN.01000401.xml

| 16.5.2019 | EN | Official Journal of the European Union | C 167/4 |
| --- | --- | --- | --- |

16.5.2019

EN

Official Journal of the European Union

C 167/4

---

Euro exchange rates (1)

15 May 2019

(2019/C 167/03)

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,1183 |
| JPY | Japanese yen | 122,24 |
| DKK | Danish krone | 7,4695 |
| GBP | Pound sterling | 0,86820 |
| SEK | Swedish krona | 10,7688 |
| CHF | Swiss franc | 1,1276 |
| ISK | Iceland króna | 137,40 |
| NOK | Norwegian krone | 9,8003 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 25,760 |
| HUF | Hungarian forint | 325,15 |
| PLN | Polish zloty | 4,3094 |
| RON | Romanian leu | 4,7615 |
| TRY | Turkish lira | 6,7780 |
| AUD | Australian dollar | 1,6166 |
| CAD | Canadian dollar | 1,5075 |
| HKD | Hong Kong dollar | 8,7784 |
| NZD | New Zealand dollar | 1,7067 |
| SGD | Singapore dollar | 1,5317 |
| KRW | South Korean won | 1 331,31 |
| ZAR | South African rand | 15,9620 |
| CNY | Chinese yuan renminbi | 7,6925 |
| HRK | Croatian kuna | 7,4183 |
| IDR | Indonesian rupiah | 16 170,62 |
| MYR | Malaysian ringgit | 4,6728 |
| PHP | Philippine peso | 58,588 |
| RUB | Russian rouble | 72,4794 |
| THB | Thai baht | 35,322 |
| BRL | Brazilian real | 4,4659 |
| MXN | Mexican peso | 21,4741 |
| INR | Indian rupee | 78,6785 |

Currency

Exchange rate

USD

US dollar

1,1183

JPY

Japanese yen

122,24

DKK

Danish krone

7,4695

GBP

Pound sterling

0,86820

SEK

Swedish krona

10,7688

CHF

Swiss franc

1,1276

ISK

Iceland króna

137,40

NOK

Norwegian krone

9,8003

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,760

HUF

Hungarian forint

325,15

PLN

Polish zloty

4,3094

RON

Romanian leu

4,7615

TRY

Turkish lira

6,7780

AUD

Australian dollar

1,6166

CAD

Canadian dollar

1,5075

HKD

Hong Kong dollar

8,7784

NZD

New Zealand dollar

1,7067

SGD

Singapore dollar

1,5317

KRW

South Korean won

1 331,31

ZAR

South African rand

15,9620

CNY

Chinese yuan renminbi

7,6925

HRK

Croatian kuna

7,4183

IDR

Indonesian rupiah

16 170,62

MYR

Malaysian ringgit

4,6728

PHP

Philippine peso

58,588

RUB

Russian rouble

72,4794

THB

Thai baht

35,322

BRL

Brazilian real

4,4659

MXN

Mexican peso

21,4741

INR

Indian rupee

78,6785

---

(1)  Source: reference exchange rate published by the ECB.

---
#### 52.214-31 Facsimile Bids.

As prescribed in 14.201-6(v), insert the following provision:

# Facsimile Bids (DEC 1989)

(a) Definition. *Facsimile bid,* as used in this solicitation, means a bid, modification of a bid, or withdrawal of a bid that is transmitted to and received by the Government via electronic equipment that communicates and reproduces both printed and handwritten material.

(b) Bidders may submit facsimile bids as responses to this solicitation. These responses must arrive at the place and by the time, specified in the solicitation.

(c) Facsimile bids that fail to furnish required representations or information or that reject any of the terms, conditions, and provisions of the solicitation may be excluded from consideration.

(d) Facsimile bids must contain the required signatures.

(e) The Government reserves the right to make award solely on the facsimile bid. However, if requested to do so by the Contracting Officer, the apparently successful bidder agrees to promptly submit the complete original signed bid.

(f) Facsimile receiving data and compatibility characteristics are as follows:

(1) Telephone number of receiving facsimile equipment:

(2) Compatibility characteristics of receiving facsimile equipment (e.g., make and model number, receiving speed, communications protocol):

(g) If the bidder chooses to transmit a facsimile bid, the Government will not be responsible for any failure attributable to the transmission or receipt of the facsimile bid including, but not limited to, the following:

(1) Receipt of garbled or incomplete bid.

(2) Availability or condition of the receiving facsimile equipment.

(3) Incompatibility between the sending and receiving equipment.

(4) Delay in transmission or receipt of bid.

(5) Failure of the bidder to properly identify the bid.

(6) Illegibility of bid.

(7) Security of bid data.

(End of provision)

[54 FR 48992, Nov. 28, 1989, as amended at 64 FR 51841, Sept. 24, 1999]
# C_2021079EN.01000101.xml

| 8.3.2021 | EN | Official Journal of the European Union | C 79/1 |
| --- | --- | --- | --- |

8.3.2021

EN

Official Journal of the European Union

C 79/1

---

Last publications of the Court of Justice of the European Union in the Official Journal of the European Union

(2021/C 79/01)

Last publication

OJ C 72, 1.3.2021

Past publications

OJ C 62, 22.2.2021

OJ C 53, 15.2.2021

OJ C 44, 8.2.2021

OJ C 35, 1.2.2021

OJ C 28, 25.1.2021

OJ C 19, 18.1.2021

These texts are available on:

EUR-Lex: http://eur-lex.europa.eu

---
-82 -80 -78 -76 -74 -72 -70

 36

 38

 40

 42

★

▲

▲

▲

▲

★ ▲

▲

▲

▲

 500

 1000

 1500

 2000

 500

18 12 06 00

05/30

NOAA HYSPLIT MODEL

 Backward trajectory ending at 2300 UTC 30 May 06

 EDAS Meteorological Data

Source

★ at 38.92 N 77.01 W Meters AGL
#### 225.7202 Exception.

This subpart does not apply to contracts for commercial products, commercial services, construction, ores, natural gas, utilities, petroleum products and crudes, timber (logs), or subsistence.

[70 FR 20839, Apr. 22, 2005, as amended at 88 FR 6584, Jan. 31, 2023]
Discover MyPlate • http://teamnutrition.usda.gov • May 2014 • FNS-470 • USDA is an equal opportunity provider and employer.

The Fruit Group

The Vegetable Group

The Dairy Group

The Grains Group

The Protein Foods Group

The Five Food Groups
#### 449.111 Review of proposed settlements.

Proposed settlement agreements shall be reviewed and approved in accordance with contracting activity procedures.
- Skip to main content
- About Us
- Contact Us
- FAQs
-  Language Assistance ****   - English
  - español
  - 中文: 繁體版
  - Việt-ngữ
  - 한국어
  - Tagalog
  - Русский

U.S. Department of Education

U.S. Department of Education

            - Student Loans
            - Grants
            - Laws
            - Data

|                                       |
|---------------------------------------|
|                                       | PurposeFunding StatusEligibilityLaws, Regs, & GuidanceApplicant InfoResourcesSurplus PropertiesFAQsPerformanceContacts |  |
| Office of Finance and Operations Home |
|                                       |

## Available Surplus Properties

A  List of Eligible Program Examples (PDF, 28KB)

How to Acquire Surplus Federal Real Property For Educational Purposes

----

 

 Printable view

## How Do I Find...

          - Student loans, forgiveness
          - Higher Education Rulemaking
          - College accreditation
          - Every Student Succeeds Act (ESSA)
          - FERPA
          - FAFSA
          - 1098, tax forms

More >

## Information About...

          - Elevating Teaching
          - Early Learning
          - Engage Every Student
          - Unlocking Career Success
          - Cybersecurity

 

----

*Our mission*

Student Loans
Repaying LoansDefaulted LoansLoan ForgivenessLoan Servicers

Grants & Programs
Apply for Pell GrantsGrants ForecastApply for a Grant

Laws & Guidance
Every Student Succeeds Act (ESSA)FERPACivil RightsNew IDEA Website

Data & Research
Education StatisticsPostsecondary Education DataED Data ExpressNation's Report CardWhat Works ClearinghouseOpen Data PlatformCOVID Relief Data

About Us
Contact UsED OfficesJobsPress ReleasesFAQsRecursos en españolBudget, PerformancePrivacy Program

----

          - Notices
          - FOIA
          - Privacy Policy
          - Accessibility
          - Security
          - Information quality
          - Inspector General
          - Whitehouse.gov
          - USA.gov
          - Benefits.gov
          - Regulations.gov
          - vote.gov
- All
            - Title
            - Author
            - Subject
            - Date
            - Full-Text

            -                              Explore                            ******                - Educational Resources
              - Archival Collections
              -                                      Themes                                    ******                  - Economic Data
                - Federal Reserve
                - View all 
              - Timelines 
            -                              Browse                            ******                - Titles
              - Authors
              - Subjects
              - Dates 
            -                              About                            ******                - About FRASER
              - FAQ
              - Contact Us
              -                                      FRASER API                                    ******                  - REST API
                - OAI-PMH 
            - Inside FRASER Blog

            - **

Home                 > Browse by Title > Amendment of Section 14(b) of the Federal Reserve Act

              																	United States. Congress. House. Committee on Banking and Currency. Subcommittee No. 1					,	Roosa, Robert V.					 and 	Eighty-Seventh Congress, 1961-1963. 						*Amendment of Section 14(b) of the Federal Reserve Act : Hearing Before Subcommittee No. 1 of the Committee on Banking and Currency, House of Representatives, Eighty-Seventh Congress, Second Session, on H. R. 11654, June 19, 1962*,												Washington: 								Government Printing Office, 										June 19, 1962,									https://fraser.stlouisfed.org/title/372,			accessed on September 22, 2024.						    

        - **FRASER**
        - About
        - FAQ
        - Legal and Privacy
        - FRASER API

          -                              @FedFRASER 
          - ** Contact Us
          -  **  What's New  
          -  **  Inside FRASER
**EXHIBIT 31.1** **CERTIFICATION**     I, Andrew J. Fromkin, certify that:     1. I have reviewed this annual report on    Form 10-K    of Clinical Data, Inc.;     2. Based on my knowledge, this report does not contain any    untrue statement of a material fact or omit to state a material    fact necessary to make the statements made, in light of the    circumstances under which such statements were made, not    misleading with respect to the period covered by this report;     3. Based on my knowledge, the financial statements, and    other financial information included in this report, fairly    present in all material respects the financial condition,    results of operations and cash flows of the registrant as of,    and for, the periods presented in this report;     4. The registrant’s other certifying officer and I are    responsible for establishing and maintaining disclosure controls    and procedures (as defined in Exchange Act    Rules 13a-15(e)    and    15d-15(e)    for the registrant and have:     a. Designed such disclosure controls and procedures, or    caused such disclosure controls and procedures to be designed    under our supervision, to ensure that material information    relating to the registrant, including its consolidated    subsidiaries, is made known to us by others within those    entities, particularly during the period in which this report is    being prepared;     b. [Paragraph omitted in accordance with SEC transition    instructions contained in SEC    Release 34-47986]     c. Evaluated the effectiveness of the registrant’s    disclosure controls and procedures and presented in this report    our conclusions about the effectiveness of the disclosure    controls and procedures, as of the end of the period covered by    this report based on such evaluation; and     d. Disclosed in this report any change in the    registrant’s internal control over financial reporting that    occurred during the registrant’s most recent fiscal quarter    (the registrant’s fourth fiscal quarter in the case of an    annual report) that has materially affected, or is reasonably    likely to materially affect, the registrant’s internal    control over financial reporting; and     5. The registrant’s other certifying officer and I    have disclosed, based on our most recent evaluation of internal    control over financial reporting, to the registrant’s    auditors and the audit committee of the registrant’s board    of directors (or persons performing the equivalent functions):     a. All significant deficiencies and material weaknesses in    the design or operation of internal control over financial    reporting which are reasonably likely to adversely affect the    registrant’s ability to record, process, summarize and    report financial information; and     b. Any fraud, whether or not material, that involves    management or other employees who have a significant role in the    registrant’s internal control over financial reporting. /s/  Andrew    J. Fromkin    Andrew J. Fromkin    President and Chief Executive Officer     Date: June 19, 2007
#### 48.104-4 Sharing alternative—no-cost settlement method.

In selecting an appropriate mechanism for incorporating a VECP into a contract, the contracting officer shall analyze the different approaches available to determine which one would be in the Government's best interest. Contracting officers should balance the administrative costs of negotiating a settlement against the anticipated savings. A no-cost settlement may be used if, in the contracting officer's judgment, reliance on other VECP approaches likely would not be more cost-effective, and the no-cost settlement would provide adequate consideration to the Government. Under this method of settlement, the contractor would keep all of the savings on the instant contract, and all savings on its concurrent contracts only. The Government would keep all savings resulting from concurrent contracts placed with other sources, savings from all future contracts, and all collateral savings. Use of this method must be by mutual agreement of both parties for individual VECPs.

[63 FR 34079, June 22, 1998. Redesignated at 64 FR 51847, Sept. 24, 1999]
<PAGE>   1


                    AMENDMENT TO EXECUTIVE STOCK OPTION PLAN
                             OF CERTRON CORPORATION


        The Executive Stock Option Plan of Certron Corporation, as amended (the
"Plan"), is hereby further amended as follows:

        1. Amended paragraph (a) of Section 5 of the Plan is further amended by
changing the number "300,000" appearing therein to the number "600,000."

        2. Amended Section 16 of the Plan is amended by deleting the first
sentence thereon in its entirety and substituting in lieu thereof the following
sentence: "The Plan shall terminate on January 24, 2011 but such termination
shall not affect the validity of any outstanding Options or Stock Appreciation
Rights or any restrictions or agreements contained therein."












                                  EXHIBIT 10.1


                                       14